Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 02 2019
Historique:
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 4 12 2019
Statut: epublish

Résumé

Resistance of gram-negative bacilli to carbapenems is rapidly emerging worldwide. In 2016, the World Health Organization defined the hospital-built environment as a core component of infection prevention and control programs. The hospital-built environment has recently been reported as a source for outbreaks and sporadic transmission events of carbapenemase-producing gram-negative bacilli from the environment to patients. To assess risk after the identification of an unexpected, severe, and lethal hospital-acquired infection caused by carbapenemase-producing Pseudomonas aeruginosa in a carbapenemase-low endemic setting. A case series study in which a risk assessment was performed on all 11 patients admitted to the combined cardiothoracic surgery and pulmonary diseases ward and the hospital-built environment in the Radboud University Medical Center, the Netherlands, in February 2018. Water and aerosols containing carbapenemase-producing (Verona integron-mediated metallo-β-lactamase [VIM]) P aeruginosa. Colonization and/or infection of patients and/or contamination of the environment after the detection of 1 patient infected with carbapenemase-producing (VIM) P aeruginosa. A total of 5 men (age range, 60-84 years) and 6 women (age range, 55-74 years) were admitted to the combined cardiothoracic surgery and pulmonary diseases ward. The risk assessment was performed after carbapenemase-producing (VIM) P aeruginosa was unexpectedly detected in a man in his early 60s, who had undergone a left-sided pneumonectomy and adjuvant radiotherapy. No additional cases (colonization or infection) of carbapenemase-producing (VIM) P aeruginosa were detected. Plausible transmission of carbapenemase-producing P aeruginosa from the hospital environment to the patient via the air was confirmed by whole-genome sequencing, which proved the relation of Pseudomonas strains from the patient, the shower drains in 8 patient rooms, 1 sink, and an air sample. This study suggests that rethinking the hospital-built environment, including shower drains and the sewage system, will be crucial for the prevention of severe and potential lethal hospital-acquired infections.

Identifiants

pubmed: 30768189
pii: 2724770
doi: 10.1001/jamanetworkopen.2018.7665
pmc: PMC6484879
doi:

Substances chimiques

Bacterial Proteins 0
Carbapenems 0
beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e187665

Commentaires et corrections

Type : CommentIn

Références

Antimicrob Resist Infect Control. 2017 Jun 10;6:59
pubmed: 28616203
Clin Infect Dis. 2017 May 15;64(10):1435-1444
pubmed: 28200000
Clin Infect Dis. 2018 Jul 2;67(2):171-178
pubmed: 29409044
Lancet Infect Dis. 2011 May;11(5):355-62
pubmed: 21478057
Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1463-8
pubmed: 27259712
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Antimicrob Resist Infect Control. 2017 Nov 15;6:113
pubmed: 29163939
J Hosp Infect. 2018 Mar;98(3):275-281
pubmed: 29104124
MMWR Morb Mortal Wkly Rep. 2018 Jun 15;67(23):668-669
pubmed: 29902165
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
mBio. 2018 Feb 6;9(1):
pubmed: 29437920
Bioinformatics. 2015 Sep 1;31(17):2877-8
pubmed: 25913206
Biofouling. 2011 Oct;27(9):1017-32
pubmed: 22011093
Ophthalmic Epidemiol. 2011 Jun;18(3):99-102
pubmed: 21609237
Water Res. 2018 Mar 1;130:47-57
pubmed: 29197756
Lancet Infect Dis. 2018 Mar;18(3):e99-e106
pubmed: 29102325
Infect Control Hosp Epidemiol. 2018 Nov;39(11):1307-1315
pubmed: 30284524

Auteurs

Joost Hopman (J)

Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Corianne Meijer (C)

Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Nikki Kenters (N)

Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Jordy P M Coolen (JPM)

Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Mohammad R Ghamati (MR)

Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Shaheen Mehtar (S)

Academic Unit for Infection Prevention and Control, Department of Interdisciplinary Health Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa.

Reinout van Crevel (R)

Center for Infectious Diseases, Department of Internal Medicine Radboudumc, Radboud University Medical Center, Nijmegen, the Netherlands.

Wim J Morshuis (WJ)

Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Ad F T M Verhagen (AFTM)

Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Michel M van den Heuvel (MM)

Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.

Andreas Voss (A)

Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.

Heiman F L Wertheim (HFL)

Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH